TRASTUZUMAB-DTTB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where TRASTUZUMAB-DTTB was used for Neoplasm malignant.
Most Reported Side Effects for TRASTUZUMAB-DTTB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 150 | 30.2% | 1 | 133 |
| Product use in unapproved indication | 89 | 17.9% | 4 | 83 |
| Nausea | 66 | 13.3% | 0 | 54 |
| Pyrexia | 65 | 13.1% | 1 | 62 |
| Off label use | 63 | 12.7% | 3 | 56 |
| Anaemia | 61 | 12.3% | 0 | 55 |
| Vomiting | 46 | 9.3% | 0 | 38 |
| Hypokalaemia | 43 | 8.7% | 0 | 43 |
| Chills | 40 | 8.1% | 1 | 22 |
| Dyspnoea | 37 | 7.4% | 0 | 21 |
| Acute kidney injury | 31 | 6.2% | 0 | 31 |
| Abdominal pain | 26 | 5.2% | 0 | 21 |
| General physical health deterioration | 26 | 5.2% | 3 | 23 |
| Fatigue | 25 | 5.0% | 0 | 19 |
| Headache | 25 | 5.0% | 0 | 16 |
Other Indications for TRASTUZUMAB-DTTB
Breast cancer (143)
Oesophageal adenocarcinoma (98)
Breast cancer female (61)
Her2 positive breast cancer (59)
Product used for unknown indication (38)
Breast cancer metastatic (34)
Her2 positive gastric cancer (10)
Invasive ductal breast carcinoma (8)
Adenocarcinoma gastric (6)
Breast neoplasm (5)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)